Hyo. - not sure what your knowledge is about the biotech industry and trials, etc however Decan has been pretty consistent with what I have been saying for the past couple of months.
They've only done trials on around 30 people for ovarian cancer. Will need 500+ at least, but probably closer to 1000.
Tough call to suggest someone is a "downramper" when they are presenting factual information. Maybe its because his content doesn't suit what you want it to - good to see a few have a reality check in here. Too many bought in the hype and are now doing there research, hence a few of Hotcopper people selling out. Pity the big guys were selling to the little guys during the hype
time to hear from management, page-14
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.015(4.41%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $1.270M | 3.611M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 286261 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 253490 | 7 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |